PACS is MIMPS | AI Trough | Long Haul Imaging
“No way am I going to be known as the MIMPSMan.” A LinkedIn comment from the “PACSMan” Michael J. Cannavo after the FDA changed PACS’ name…
RP’s Big Week | Hyperfine Redefines | Mobile TB
“Somehow, buying essential medical equipment has grown into its own industry.” Hyperfine’s Chris Ward on why the portable MRI startup decided to simplify the MRI buying…
AI-Guided Milestone | Watson Options | The Unmatched
“Fear of AI is a decadent, first-world problem.” UPenn Prof. Saurabh Jha during his keynote speech at the recently-posted Michigan AI 2020 Symposium. Imaging Wire Sponsors…
AI in 2021 | CT + EMR | Bone DBT
“The vaccination rollout, all well-intentioned, hit the perfect storm.” Stanford Medical Center after its vaccine prioritization algorithm skipped over many frontline residents and fellows. Imaging Wire…
Rad Blindness | Philips Prevails | CO-RADS Works
“. . . we need to be doing a lot more testing,” Google Brain scientist, Alex D’Amour, on the underspecification problem that’s creating AI’s real world…
Equal Extenders | Google Responds | Follow the Money
“I hate it.” How Dr. Luke Oakden-Rayner really feels about last week’s paper criticizing Google’s mammography AI study (even though he respects the authors “a lot”).…
CV19 POCUS Network | PE Surge | First Tau Agent
“widespread upheaval in the US health care may lead to a surge of purchases by PE firms of distressed hospitals and other health care firms.” A…
ACR Takes a Stand | COVID-19’s Volume Impact
“ . . . any boards certifying diagnostic radiologists, interventional radiologists, nuclear medicine physicians, radiation oncologists, and medical physicists should minimize power imbalance in decision-making between…
Federal Flexibility | Protecting the Techs
“. . . it’s yet another stellar example of the ABR’s heavy-handed tone-deaf approach to just about everything within its tiny little purview” Ben White on…
CV19 AI Works | The SmartBra | Opening the CV19 Bottleneck
“. . . vendors of medical imaging AI were already battling with convincing payers prior to the pandemic, and there is no reason to suspect that…
